Early outcomes of high-dose-rate brachytherapy combined with ultra-hypofractionated radiation in higher-risk prostate cancer.

Gorovets, Daniel; Hopkins, Margaret; Kollmeier, Marisa; Moore, Assaf; Goel, Arun; Shasha, Daniel; Brennan, Victoria; McBride, Sean; Cohen, Gilad; Damato, Antonio L; Zelefsky, Michael J

Gorovets, Daniel; Hopkins, Margaret; Kollmeier, Marisa; Moore, Assaf; Goel, Arun; Shasha, Daniel; Brennan, Victoria; McBride, Sean; Cohen, Gilad; Damato, Antonio L; Zelefsky, Michael J.

Afiliación

Gorovets D; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address: gorovetd@mskcc.org.
Hopkins M; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
Kollmeier M; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
Moore A; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Goel A; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
Shasha D; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
Brennan V; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
McBride S; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
Cohen G; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY.
Damato AL; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY.
Zelefsky MJ; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.

Brachytherapy ; 20(6): 1099-1106, 2021.

Article en En | MEDLINE | ID: mdl-34588146

Asunto(s)

Braquiterapia; Neoplasias de la Próstata; Antagonistas de Andrógenos; Braquiterapia/métodos; Humanos; Masculino; Antígeno Prostático Específico; Neoplasias de la Próstata/radioterapia; Hipofraccionamiento de la Dosis de Radiación

Palabras clave

CTCAE, Common Terminology Criteria for Adverse Events; CTV, clinical target volume; EBRT, external beam radiation therapy; EPE, extra-prostatic extension; EPIC, Expanded Prostate Cancer Index Composite; GI, gastrointestinal; GU, genitourinary; HDR, high-dose rate; High dose rate brachytherapy; IMRT, intensity-modulated radiation therapy; IPSS, International Prostate Symptom Score; LDR, low-dose rate; NCCN, National Comprehensive Cancer Network; OARS, organs at risk; PET, positron emission tomography; PFS, progression-free survival; PRO, patient-reported outcomes; PSA, prostate-specific antigen; PSMA, prostate-specific membrane antigen; PTV, planning target volume; Prostate cancer; SBRT, stereotactic body radiation therapy; Stereotactic radiosurgery; Toxicity. Abbreviations: ADT, androgen deprivation therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Braquiterapia Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Brachytherapy Asunto de la revista: RADIOTERAPIA Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google